Goldman will study Diamond Blackfin Anemia, a rare, childhood bone marrow failure syndrome.
Friedman will conduct research on medulloblastoma, the most common malignant brain tumor found in children.
Events will be held across the Birmingham area for Breast Cancer Awareness Month.
Discovery may broaden clinical applications for a class of drugs that show promise for the treatment of familial breast and ovarian cancer.
UAB research team finds protein TLR9 holds key to predicting survival and aggressiveness of triple negative breast cancer.
New director to help establish UAB as the South’s leading center for treating leukemia, lymphoma, multiple myeloma and related diseases.
UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.